HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
173304.0,283256,2160-12-25 06:38:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
   8 hr post cath check unremarkable.
   Allergies:
   Sulfonamides
   Unknown;
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2160-12-24**] 10:00 PM
   Morphine Sulfate - [**2160-12-25**] 02:20 AM
   Other medications:
   Atorvastatin 80mg
   Heparin 5000u sc
   Colace 100mg [**Hospital1 7**]
   ASA 325 daily
   Plavix 75mg
   Prns:
   APAP
   Morphine Sulfate IV
   Senna
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-25**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 56 (51 - 63) bpm
   BP: 100/66(74) {88/58(62) - 109/75(81)} mmHg
   RR: 23 (11 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
             Total In:
                                                                  1,284 mL
                                                                    405 mL
   PO:
                                                                    240 mL
             TF:
   IVF:
                                                                  1,044 mL
                                                                    405 mL
   Blood products:
   Total out:
                                                                    450 mL
                                                                    325 mL
   Urine:
                                                                    450 mL
                                                                    325 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    834 mL
                                                                     80 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   163 K/uL
   13.6 g/dL
   4.5 mEq/L
   106 mEq/L
   139 mEq/L
   37.9 %
   17.1 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
   WBC
   17.1
   Hct
   37.9
   Plt
   [**Telephone/Fax (3) 3547**]
   TropT
   10.95
   8.17
   Other labs: CK / CKMB / Troponin-T:2900/204/8.17
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia. Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.
   - Start high dose ASA, plavix, high dose statin
   - Start bblocker, ACE-I as blood pressure and HR tolerates
   - Follow CE's until peak
   - Ck HgA1C for risk reduction
   - 2hr platelet ck while on integrillin
   - Post cath ck this evening
   - Morphine PRN for CP
   .
   #. Pump: No history of CHF by history or symptoms. [**Month (only) 51**] have component
   of diastolic dysfunction given history of hypertension.
   - Evaluate with ECHO
   .
   #. Rhythm: Sinus bradycardia. Hold on bblocker for now.
   - Monitor on tele
   .
   #. Borderline HTN:
   - monitor BP's on cardiac meds
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 in AM
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2160-12-24**] 10:00 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","Based on the provided information, the patient is a 59-year-old male with a medical history of coronary artery disease (CAD), including a previous right coronary artery (RCA) stent placement. The patient presented with an inferior STEMI and was found to have in-stent thrombosis and restenosis of the prior RCA stent. He underwent stenting of the proximal RCA.

The patient's current vital signs include a temperature of 36.6°C (97.9°F), heart rate of 56 bpm, blood pressure ranging from 100/66mmHg to 74/58mmHg, respiratory rate of 23 breaths per minute, and oxygen saturation of 97%. The patient is on mechanical ventilation support.

Physical examination reveals a well-nourished middle-aged male who is alert and oriented. There are no signs of pallor or cyanosis in the oral mucosa, and the sclera is anicteric. The patient's neck is supple with a jugular venous pressure (JVP) of 8 cm. The point of maximal impulse (PMI) is located in the 5th intercostal space at the midclavicular line, with normal S1 and S2 heart sounds. There are no murmurs, gallops, or rubs heard. The lungs are clear to auscultation bilaterally, and there are no abnormalities in the abdomen. The patient's extremities are cool and clam"
173304.0,283256,2160-12-25 06:38:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
   8 hr post cath check unremarkable.  Patient c/o mild CP o/n, resolved
   with Morphine, no EKG changes.
   Allergies:
   Sulfonamides
   Unknown;
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2160-12-24**] 10:00 PM
   Morphine Sulfate - [**2160-12-25**] 02:20 AM
   Other medications:
   Atorvastatin 80mg
   Heparin 5000u sc
   Colace 100mg [**Hospital1 7**]
   ASA 325 daily
   Plavix 75mg
   Prns:
   APAP
   Morphine Sulfate IV
   Senna
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-25**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 56 (51 - 63) bpm
   BP: 100/66(74) {88/58(62) - 109/75(81)} mmHg
   RR: 23 (11 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
             Total In:
                                                                  1,284 mL
                                                                    405 mL
   PO:
                                                                    240 mL
             TF:
   IVF:
                                                                  1,044 mL
                                                                    405 mL
   Blood products:
   Total out:
                                                                    450 mL
                                                                    325 mL
   Urine:
                                                                    450 mL
                                                                    325 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    834 mL
                                                                     80 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   137
                               [image002.gif]
                                     103
                               [image002.gif]
                                     15
   [image004.gif]
   106
                                                                   AGap=15
   [image005.gif]
   5.0
                               [image002.gif]
                                     24
                               [image002.gif]
                                     0.9
   [image007.gif]
   CK: 2195
   MB: 128
   MBI: 5.8
   Trop-T: 6.80
   Ca: 8.4 Mg: 2.1 P: 2.5
   89
                                                                      16.8
                                                            [image007.gif]
                                    13.3
   [image004.gif]
   156
                 [image008.gif]
   [image004.gif]
                                    36.7
   [image007.gif]
   PT: 12.3
   PTT: 26.5
   INR: 1.0
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
   WBC
   17.1
   Hct
   37.9
   Plt
   [**Telephone/Fax (3) 3547**]
   TropT
   10.95
   8.17
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin
   - Start Lisinopril 2.5mg, add BB if pressures tolerate
   - Morphine PRN for CP
   .
   #. Pump:  Patient with elevated JVP, c/w presentation.  Echo shows
   40-45% EF.
   .
   #. Rhythm: Sinus bradycardia. Hold on bblocker for now.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 if pt stable.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2160-12-24**] 10:00 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","Summary:
The patient is a 59-year-old male with a history of coronary artery disease (CAD) who presented with an inferior ST-elevation myocardial infarction (STEMI). He had undergone a percutaneous coronary intervention (PCI) with stent placement in the right coronary artery (RCA) and was found to have in-stent thrombosis and restenosis of the prior RCA stent. He underwent another stent placement in the proximal RCA. The patient's electrocardiogram (EKG) shows inferoposterolateral ischemia, and cardiac catheterization revealed RCA disease with 40% stenosis in the left anterior descending artery (LAD) and left circumflex artery (LCX), as well as a myocardial bridge. The patient's risk factors for CAD include borderline hypertension and dyslipidemia. His most recent lipid panel showed a low-density lipoprotein (LDL) level of 123. The patient's heart rate (HR) and blood pressures have been improving.

Assessment and Plan:
1. CAD: Continue aspirin (ASA), clopidogrel (Plavix), and high-dose statin therapy.
2. Pump: The patient has elevated jugular venous pressure (JVP) consistent with his presentation. An echocardiogram shows a 40-45% ejection fraction (EF).
3. Rhythm: Sinus bradycardia. Hold on beta-blocker for now.
4. Hyperlipidemia: Start high-dose statin therapy.
5. Fluid-Electrolyte-Nutrition (FEN): Cardiac diet. Follow and replete electrolytes.
6. Access: Peripheral intravenous (PIV) line.
7. Pre-procedural: PO diet.
8. Code: Full code.
9. Contact: Girlfriend for 26 years, [First Name] [Last Name], [phone number].
10. Disposition: Continue care in the critical care unit (CCU) for now; will likely transfer to [Hospital Ward Name] 3 if stable.

Potential Medical Complications:
1. Cardiac complications: Given the patient's history of CAD and recent STEMI, there is a risk of further cardiac events such as recurrent myocardial infarction, heart failure, arrhythmias, or cardiogenic shock.
2. Thrombosis: The patient had in-stent thrombosis, which is a potential complication of stent placement. There is a risk of further thrombotic events in the stented vessels or other coronary arteries.
3. Restenosis: The patient had restenosis of the prior RCA stent, which may require further intervention.
4. Hypotension: The patient's blood pressures have been improving, but there is still a risk of hypotension, especially if beta-blocker therapy is initiated or if there are complications such as heart failure or arrhythmias.
5. Bradycardia: The patient is currently experiencing sinus bradycardia, which can be a side effect of beta-blocker therapy."
173304.0,283256,2160-12-26 06:42:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2160-12-25**] 08:00 AM
   Allergies:
   Sulfonamides
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2160-12-25**] 09:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-26**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (100.9
   Tcurrent: 37.4
C (99.3
   HR: 70 (60 - 77) bpm
   BP: 106/70(79) {93/53(62) - 110/73(80)} mmHg
   RR: 22 (16 - 28) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                                                                  1,045 mL
                  PO:
                                                                    640 mL
                  TF:
   IVF:
                                                                    405 mL
   Blood products:
   Total out:
                                                                  1,375 mL
                                                                    550 mL
   Urine:
                                                                  1,375 mL
                                                                    350 mL
   NG:
   Stool:
   200 mL
   Drains:
   Balance:
                                                                   -330 mL
                                                                   -550 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 93%
   ABG: ///24/
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   180 K/uL
   14.6 g/dL
   97 mg/dL
   1.1 mg/dL
   24 mEq/L
   4.1 mEq/L
   20 mg/dL
   107 mEq/L
   142 mEq/L
   41.6 %
   17.5 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
                            [**2160-12-25**]  06:25 AM
                            [**2160-12-26**]  05:12 AM
   WBC
   17.1
   16.8
   17.5
   Hct
   37.9
   36.7
   41.6
   Plt
   [**Telephone/Fax (3) 3586**]56
   180
   Cr
   0.9
   1.1
   TropT
   10.95
   8.17
   6.80
   Glucose
   106
   97
   Other labs: PT / PTT / INR:12.8/27.2/1.1, CK / CKMB /
   Troponin-T:2195/128/6.80, Ca++:8.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin.
   - start low dose metoprolol, switch captopril to lisinopril
   .
   #. Pump:  Patient with elevated JVP, c/w RV failure presentation.  Echo
   shows 40-45% EF.
   .
   #. Rhythm: NSR with HR on low side.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.  SC Heparin
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: Call out today.
   1. IV access: Peripheral line, Date inserted: [**2160-12-24**] Order date:
   [**12-24**] @ 1019
   8. Heparin 5000 UNIT SC TID  Order date: [**12-24**] @ 1019
   2. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-24**] @ 1019
   9. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-24**] @ 1013
   3. Aspirin EC 325 mg PO DAILY  Order date: [**12-24**] @ 0934
   10. Morphine Sulfate 1-2 mg IV Q4H:PRN Pain
   Please hold for sedation or RR < 12.  Order date: [**12-24**] @ 1712
   4. Atorvastatin 80 mg PO DAILY  Order date: [**12-24**] @ 1019
   11. Senna 1 TAB PO BID:PRN  Order date: [**12-24**] @ 1019
   5. Captopril 3.125 mg PO TID
   Hold for SBP < 90  Order date: [**12-25**] @ 1326
   12. Sertraline 75 mg PO DAILY  Order date: [**12-25**] @ 1549
   6. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-24**] @ 0934
   13. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-24**] @ 1019
   7. Docusate Sodium 100 mg PO BID  Order date: [**12-24**] @ 1019
","Based on the provided progress note, the patient is a 59-year-old male with a medical history of coronary artery disease (CAD) who presented with an inferior ST-elevation myocardial infarction (STEMI). The patient had undergone a percutaneous coronary intervention (PCI) with stent placement in the right coronary artery (RCA) due to in-stent thrombosis and restenosis of a prior RCA stent.

The patient's current assessment includes:

1. CAD: The EKG shows inferoposterolateral ischemia, and there are persistent ST elevations and Q waves in leads II, III, and aVF. The cardiac catheterization revealed RCA disease with a previously placed drug-eluting stent, along with 40% stenosis in the left anterior descending (LAD) artery and the left circumflex artery (LCX), as well as a myocardial bridge. The patient's risk factors for CAD include borderline hypertension and dyslipidemia.

Plan:
- Continue ASA (aspirin), clopidogrel (Plavix), and high-dose statin.
- Start low-dose metoprolol and switch captopril to lisinopril.

2. Pump: The patient has elevated jugular venous pressure (JVP), which is consistent with right ventricular (RV) failure presentation. An echocardiogram shows a 40-45% ejection fraction (EF).

Plan:
- Monitor"
173304.0,283256,2160-12-26 06:42:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2160-12-25**] 08:00 AM
   Allergies:
   Sulfonamides
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2160-12-25**] 09:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-26**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (100.9
   Tcurrent: 37.4
C (99.3
   HR: 70 (60 - 77) bpm
   BP: 106/70(79) {93/53(62) - 110/73(80)} mmHg
   RR: 22 (16 - 28) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                                                                  1,045 mL
                  PO:
                                                                    640 mL
                  TF:
   IVF:
                                                                    405 mL
   Blood products:
   Total out:
                                                                  1,375 mL
                                                                    550 mL
   Urine:
                                                                  1,375 mL
                                                                    350 mL
   NG:
   Stool:
   200 mL
   Drains:
   Balance:
                                                                   -330 mL
                                                                   -550 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 93%
   ABG: ///24/
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   180 K/uL
   14.6 g/dL
   97 mg/dL
   1.1 mg/dL
   24 mEq/L
   4.1 mEq/L
   20 mg/dL
   107 mEq/L
   142 mEq/L
   41.6 %
   17.5 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
                            [**2160-12-25**]  06:25 AM
                            [**2160-12-26**]  05:12 AM
   WBC
   17.1
   16.8
   17.5
   Hct
   37.9
   36.7
   41.6
   Plt
   [**Telephone/Fax (3) 3586**]56
   180
   Cr
   0.9
   1.1
   TropT
   10.95
   8.17
   6.80
   Glucose
   106
   97
   Other labs: PT / PTT / INR:12.8/27.2/1.1, CK / CKMB /
   Troponin-T:2195/128/6.80, Ca++:8.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin, captopril.
   - start low dose metoprolol, uptitrate captopril today.
   - Morphine PRN for CP
   .
   #. Pump:  Patient with elevated JVP, c/w RV failure presentation.  Echo
   shows 40-45% EF.
   .
   #. Rhythm: NSR with HR on low side.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.  SC Heparin
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 if pt stable.
   1. IV access: Peripheral line, Date inserted: [**2160-12-24**] Order date:
   [**12-24**] @ 1019
   8. Heparin 5000 UNIT SC TID  Order date: [**12-24**] @ 1019
   2. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-24**] @ 1019
   9. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-24**] @ 1013
   3. Aspirin EC 325 mg PO DAILY  Order date: [**12-24**] @ 0934
   10. Morphine Sulfate 1-2 mg IV Q4H:PRN Pain
   Please hold for sedation or RR < 12.  Order date: [**12-24**] @ 1712
   4. Atorvastatin 80 mg PO DAILY  Order date: [**12-24**] @ 1019
   11. Senna 1 TAB PO BID:PRN  Order date: [**12-24**] @ 1019
   5. Captopril 3.125 mg PO TID
   Hold for SBP < 90  Order date: [**12-25**] @ 1326
   12. Sertraline 75 mg PO DAILY  Order date: [**12-25**] @ 1549
   6. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-24**] @ 0934
   13. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-24**] @ 1019
   7. Docusate Sodium 100 mg PO BID  Order date: [**12-24**] @ 1019
","Based on the provided progress note, the patient is a 59-year-old male with a medical history of coronary artery disease (CAD) who presented with an inferior STEMI. The patient underwent stenting of the proximal right coronary artery (RCA) due to in-stent thrombosis and restenosis of a prior RCA stent.

The patient's current assessment includes:

1. Cardiovascular Assessment:
   - EKG consistent with inferoposterolateral ischemia.
   - Persistent ST elevations and Q waves in II, III, AVF.
   - Cardiac cath notable RCA disease s/p drug-eluting stent, 40% stenosis in left anterior descending (LAD) and left circumflex (LCX) arteries, as well as a myocardial bridge.
   - Risk factors for CAD include borderline hypertension and dyslipidemia, both formerly diet controlled.
   - Most recent lipid panel notable for low-density lipoprotein (LDL) of 123.
   - Patient's heart rate (HR) and blood pressures have been improving.

2. Pump Assessment:
   - Elevated jugular venous pressure (JVP), consistent with right ventricular (RV) failure presentation.
   - Echocardiogram shows an ejection fraction (EF) of 40-45%.

3. Rhythm Assessment:
   - Sinus rhythm with HR on the lower side.
   - Monitor on tele.

4. Other Assessments:
   -"
